Publications by authors named "Daniil Ahiadorme"

We describe the [Au]/[Ag]-catalyzed activation of ethynylcyclohexyl 2-azido-4,6--benzylidene mannosyl carbonates for β-mannosamine linkage preparation in high yield and selectivity in a temperature- and concentration-dependent manner. VT-NMR studies reveal an anomeric triflate intermediate generated in the absence of an acceptor alcohol that is stable up to -10 °C. The generality of the protocol was illustrated by successful application to a series of acceptors and by synthesis of a fully protected type 19F capsular trisaccharide.

View Article and Find Full Text PDF

Methyl 5-thio-α-d-galactopyranoside was synthesized and found to have a more favorable enthalpy of binding to Jacalin than methyl α-d-galactopyranoside, which is attributed to the greater magnitude of sulfur-π over oxygen-π interactions. This increase in enthalpy, however, was offset by a less favorable entropy of binding, arising from the need to constrain the more flexible thiosugar, thereby highlighting the complexities inherent in the design of effective sugar mimetics.

View Article and Find Full Text PDF

We report the synthesis of novel tetravalent glucoclusters containing 1,5-dithia mimetics of laminaribiose and triose. The new constructs were evaluated for their ability to inhibit anti-CR3 fluorescent staining of human neutrophils, for which they showed moderate affinity. Evaluation of the synthesized glycoclusters for their ability to inhibit anti-Dectin-1 fluorescent staining of mouse macrophages revealed little to no affinity for Dectin-1.

View Article and Find Full Text PDF
Article Synopsis
  • Over the last 20 years, two dangerous viruses (SARS-CoV-1 and SARS-CoV-2) were discovered to jump from animals to humans, causing serious illness and highlighting the need for new medicines to fight them.
  • Scientists studied a specific part of a bat coronavirus (PLpro) to understand how these viruses work and what makes them different, which could help in creating better treatments.
  • They developed 30 new drug-like compounds that could block the action of PLpro in these viruses and ran tests to see how effective and safe these new medicines might be.
View Article and Find Full Text PDF